Further Decision Processed by IB
06/25/2026
Back to search
Official data from USPTO
BIOCHEMFUSION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BIOCHEMFUSION
ST13
US500000079227528Class
9, 42
Filing
79227528
Registration
5521864
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
06/25/2026
Classification
Registered
Trademark type
Word
Nice classes
9, 42
Filing date
12/22/2017
Registration date
07/24/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/07/2025
Last transaction
06/25/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
24
Owner location
DK
Examiner
FRIEDMAN, LESLEE ANN
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Biochemfusion Holding ApS
Representatives
Niels Christian Døcker
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Scientific software for the management and visualization of protein sequence data and molecular entities for use in the field of life science researche.g. pharmaceutical companies
Class 42
Design and development of computer software
Publications
History of USPTO decisions and trademark events.
20 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/15/2026
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
04/15/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
04/15/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/07/2025
C71T
CANCELLED SECTION 71
02/07/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
07/11/2019
GPNX
NOTIFICATION PROCESSED BY IB
10/26/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/10/2018
FIMP
FINAL DISPOSITION PROCESSED
09/10/2018
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
08/23/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
07/24/2018
PUBO
PUBLISHED FOR OPPOSITION
05/08/2018
NPUB
NOTICE OF PUBLICATION
04/18/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/03/2018
DOCK
ASSIGNED TO EXAMINER
04/03/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/26/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
02/22/2018
Continuous trademark protection
Get notified about every new filing that threatens BIOCHEMFUSION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.